Last reviewed · How we verify
Dexmedetomidine high-dose
At a glance
| Generic name | Dexmedetomidine high-dose |
|---|---|
| Also known as | dexmedetomidine hydrochloride Injection |
| Sponsor | Fujian Provincial Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effect of Dexmedetomidine Dosage on Postoperative Delirium in Geriatric Orthopedic Surgery (PHASE2)
- Propofol-Only Versus Dexmedetomidine-Propofol in Children Undergoing Magnetic Resonance Imaging (PHASE4)
- Comparative Dose-Response of Intrathecal Dexmedetomidine for Post-Spinal Shivering (PHASE3)
- Reducing Days DELirious With DEXmedetomidine as Part of an Intensive Care Unit Sleep Promotion Bundle (EARLY_PHASE1)
- The Role of the LC-NA System in Experimental Sleep Fragmentation (PHASE1)
- Hemodynamic Effects of Fentanyl Vs Dexmedetomidine in Spine Surgery (PHASE4)
- Comparison of Caudal Block and Sacral Erector Spinae Plane Block With Dexmedetomidine in Pediatric Penile Hypospadias Repair (PHASE3)
- The Study is Being Conducted to Evaluate the Efficacy and Safety of Dexmedetomidine Hydrochloride Microneedles for Preoperative Sedation in Children (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dexmedetomidine high-dose CI brief — competitive landscape report
- Dexmedetomidine high-dose updates RSS · CI watch RSS
- Fujian Provincial Hospital portfolio CI